Novavax and Serum Institute of India – licensing agreement for Development and Commercial Collaboration
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a license agreement with Serum Institute of... Read More
Novavax, FDB agreement for large scale manufacturing of COVID-19 vaccine candidate
Posted on28 Jul 2020
Comments0
NovavaxInc, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM Diosynth Biotechnologies (FDB), a world leading CDMO for... Read More